BIBP’s COVID-19 Vaccine Approved for Emergency Use in Guyana

Mexico City, February 25 (Xinhua News Agency) - Georgetown News: The Guyana’s food and drug regulator has officially approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for emergency use in Guyana, which was announced by Dr. Frank Anthony, Minister of Health of Guyana.

      According to the local media reports, Antony said at a daily COVID-19 briefing on February 24 that Guyana’s food and drug regulator had officially approved BIBP’s COVID-19 vaccine for emergency use, and the relevant documents had been submitted to the World Health Organization.
      According to the Chinese Embassy in Guyana, the COVID-19 vaccines donated by China would be delivered to Guyana soon.